loader
Please Wait
Applying Filters...
Close
4

Seqens Seqens

X
menu

    Market Place

    Market Place

    Post Enquiry

    Post Enquiry
    menu

    Information, Expiry & Status of FDA Orange Book Patents covering Eltrombopag Olamine

    Client Email Product
    Menu

    Eltrombopag Olamine

    APIs // Active Pharmaceutical Ingredients

    PRICE INFORMATION

    INTERMEDIATES

    DOSSIERs // Finished Dosage Forms

    DRUG PRODUCT COMPOSITION

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PATENTS

    DIGITAL CONTENT

    PharmaCompass

    PharmaCompass Sponsored Ads

    PharmaCompass Sponsored Ads

    Left Arrow
    Right Arrow
    Filters Filter
    Cross PopUp
    FILTER :

    filter

    01 NOVARTIS (89)

    filter

    01 7547719 (29)

    02 7547719*PED (7)

    03 8052993 (7)

    04 8052993*PED (4)

    05 8052994 (6)

    06 8052994*PED (4)

    07 8062665 (6)

    08 8062665*PED (4)

    09 8071129 (6)

    10 8071129*PED (4)

    11 8828430 (8)

    12 8828430*PED (4)

    filter

    01 Y (29)

    02 Blank (60)

    filter

    01 Y (62)

    02 Blank (27)

    filter

    01 2025-07-13 (29)

    02 2026-01-13 (7)

    03 2027-08-01 (33)

    04 2028-02-01 (20)

    refreshReset Filter
    refresh Reset Filter
    Price Info Price Info
    product-page Product Main Page

    NOVARTIS

    Contact Supplier
    • FDA
    • EDQM
    • WHO-GMP
    Virtual Booth Upload your Marketing & Sales content on your company Virtual Booth, click HERE
    Post an Enquiry Post an Enquiry
    Flag Switzerland
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    ELTROMBOPAG OLAMINE

    PDF Supplier PDF
    URL Supplier Web Content
    8052994
    Y
    2027-08-01
    U-1714
    22291
    TREATMENT OF THROMBOCYTOPENIA IN ADULT AND PEDIATRIC PATIENTS 6 YEARS AND OLDER WITH CHRONIC IMMUNE (IDIOPATHIC) THROMBOCYTOPENIA (ITP)
    4
    ASK
    US
    PHARMACOMPASS
    Upload
    your Marketing & Sales content

    NOVARTIS

    Contact Supplier
    • FDA
    • EDQM
    • WHO-GMP
    Virtual Booth Upload your Marketing & Sales content on your company Virtual Booth, click HERE
    Post an Enquiry Post an Enquiry
    Flag Switzerland
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    ELTROMBOPAG OLAMINE

    PDF Supplier PDF
    URL Supplier Web Content
    8071129
    Y
    2027-08-01
    U-1714
    22291
    TREATMENT OF THROMBOCYTOPENIA IN ADULT AND PEDIATRIC PATIENTS 6 YEARS AND OLDER WITH CHRONIC IMMUNE (IDIOPATHIC) THROMBOCYTOPENIA (ITP)
    3
    ASK
    US
    PHARMACOMPASS
    Upload
    your Marketing & Sales content

    NOVARTIS

    Contact Supplier
    • FDA
    • EDQM
    • WHO-GMP
    Virtual Booth Upload your Marketing & Sales content on your company Virtual Booth, click HERE
    Post an Enquiry Post an Enquiry
    Flag Switzerland
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    ELTROMBOPAG OLAMINE

    PDF Supplier PDF
    URL Supplier Web Content
    7547719
    Y
    Y
    2025-07-13
    U-1575
    22291
    PATIENTS WITH SEVERE APLASTIC ANEMIA WHO HAVE HAD AN INSUFFICIENT RESPONSE TO IMMUNOSUPPRESSIVE THERAPY
    5
    ASK
    US
    PHARMACOMPASS
    Upload
    your Marketing & Sales content

    NOVARTIS

    Contact Supplier
    • FDA
    • EDQM
    • WHO-GMP
    Virtual Booth Upload your Marketing & Sales content on your company Virtual Booth, click HERE
    Post an Enquiry Post an Enquiry
    Flag Switzerland
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    ELTROMBOPAG OLAMINE

    PDF Supplier PDF
    URL Supplier Web Content
    7547719
    Y
    Y
    2025-07-13
    U-930
    22291
    TREATMENT OF IDIOPATHIC THROMBOCYTOPENIC PURPURA (ITP)
    5
    ASK
    US
    PHARMACOMPASS
    Upload
    your Marketing & Sales content

    NOVARTIS

    Contact Supplier
    • FDA
    • EDQM
    • WHO-GMP
    Virtual Booth Upload your Marketing & Sales content on your company Virtual Booth, click HERE
    Post an Enquiry Post an Enquiry
    Flag Switzerland
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    ELTROMBOPAG OLAMINE

    PDF Supplier PDF
    URL Supplier Web Content
    8052994
    Y
    2027-08-01
    U-1714
    22291
    TREATMENT OF THROMBOCYTOPENIA IN ADULT AND PEDIATRIC PATIENTS 6 YEARS AND OLDER WITH CHRONIC IMMUNE (IDIOPATHIC) THROMBOCYTOPENIA (ITP)
    1
    ASK
    US
    PHARMACOMPASS
    Upload
    your Marketing & Sales content

    NOVARTIS

    Contact Supplier
    • FDA
    • EDQM
    • WHO-GMP
    Virtual Booth Upload your Marketing & Sales content on your company Virtual Booth, click HERE
    Post an Enquiry Post an Enquiry
    Flag Switzerland
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    ELTROMBOPAG OLAMINE

    PDF Supplier PDF
    URL Supplier Web Content
    8071129
    Y
    2027-08-01
    U-1714
    22291
    TREATMENT OF THROMBOCYTOPENIA IN ADULT AND PEDIATRIC PATIENTS 6 YEARS AND OLDER WITH CHRONIC IMMUNE (IDIOPATHIC) THROMBOCYTOPENIA (ITP)
    2
    ASK
    US
    PHARMACOMPASS
    Upload
    your Marketing & Sales content

    NOVARTIS

    Contact Supplier
    • FDA
    • EDQM
    • WHO-GMP
    Virtual Booth Upload your Marketing & Sales content on your company Virtual Booth, click HERE
    Post an Enquiry Post an Enquiry
    Flag Switzerland
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    ELTROMBOPAG OLAMINE

    PDF Supplier PDF
    URL Supplier Web Content
    8052993
    Y
    2027-08-01
    U-1306
    22291
    TREATMENT OF THROMBOCYTOPENIA IN PATIENTS WITH CHRONIC HEPATITIS C TO ALLOW THE INITIATION AND MAINTENANCE OF INTERFERON-BASED THERAPY
    1
    ASK
    US
    PHARMACOMPASS
    Upload
    your Marketing & Sales content

    NOVARTIS

    Contact Supplier
    • FDA
    • EDQM
    • WHO-GMP
    Virtual Booth Upload your Marketing & Sales content on your company Virtual Booth, click HERE
    Post an Enquiry Post an Enquiry
    Flag Switzerland
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    ELTROMBOPAG OLAMINE

    PDF Supplier PDF
    URL Supplier Web Content
    8052993
    Y
    2027-08-01
    U-2451
    22291
    1
    ASK
    US
    PHARMACOMPASS
    Upload
    your Marketing & Sales content

    NOVARTIS

    Contact Supplier
    • FDA
    • EDQM
    • WHO-GMP
    Virtual Booth Upload your Marketing & Sales content on your company Virtual Booth, click HERE
    Post an Enquiry Post an Enquiry
    Flag Switzerland
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    ELTROMBOPAG OLAMINE

    PDF Supplier PDF
    URL Supplier Web Content
    7547719
    Y
    Y
    2025-07-13
    U-1575
    22291
    PATIENTS WITH SEVERE APLASTIC ANEMIA WHO HAVE HAD AN INSUFFICIENT RESPONSE TO IMMUNOSUPPRESSIVE THERAPY
    2
    ASK
    US
    PHARMACOMPASS
    Upload
    your Marketing & Sales content

    NOVARTIS

    Contact Supplier
    • FDA
    • EDQM
    • WHO-GMP
    Virtual Booth Upload your Marketing & Sales content on your company Virtual Booth, click HERE
    Post an Enquiry Post an Enquiry
    Flag Switzerland
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    ELTROMBOPAG OLAMINE

    PDF Supplier PDF
    URL Supplier Web Content
    7547719
    Y
    Y
    2025-07-13
    U-2452
    22291
    2
    ASK
    US
    PHARMACOMPASS
    Upload
    your Marketing & Sales content
    Post Enquiry
    POST ENQUIRY